Do all patients with breast cancer require systemic adjuvant therapy?
- PMID: 21881041
- PMCID: PMC3176780
- DOI: 10.1093/jnci/djr331
Do all patients with breast cancer require systemic adjuvant therapy?
Comment on
-
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88. doi: 10.1093/jnci/90.18.1371. J Natl Cancer Inst. 1998. PMID: 9747868 Clinical Trial.
References
-
- Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792. - PubMed
-
- Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717. - PubMed
-
- Cortes J, Saura C, Bellet M, et al. HER2 and hormone receptor-positive breast cancer—blocking the right target. Nat Rev Clin Oncol. 2011;8(5):307–311. - PubMed
-
- Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998;16(2):515–521. - PubMed
-
- Lindley C, Vasa S, Sawyer WT, et al. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998;16(4):1380–1387. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical